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Abstract  
 Activated T cells are known to promote fibrosis, a major complication limiting the range of 
polymeric hydrogels as artificial corneal implants. As T cells are activated by dendritic cells (DC), 
minimally activating hydrogels would be optimal. In this study, we evaluated the ability of a series of 
engineered (manufactured/fabricated) and natural collagen matrices to either activate DC or conversely 
induce DC apoptosis in vitro. Bone marrow DC were cultured on a series of singly and doubly 
crosslinked hydrogels (made from recombinant human collagen, RHCIII; or collagen mimetic peptide, 
CMP); or on natural collagen-containing matrices, MatrigelTM and de-cellularised mouse corneal 
stroma. Dendritic cell surface expression of MHC Class II and CD86 as well as apoptosis markers were 
examined. Natural matrices induced low levels of DC activation and maintained a “tolerogenic” 
phenotype. The same applied to singly crosslinked CMP-PEG gels. RHCIII gels singly crosslinked 
using either N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide with the co-initiator N-hydroxy 
succinimide (EDC-NHS) or N-cyclohexyl-N-(2-morpholinoethyl) carbodiimide metho-p-
toulenesulfonate with NHS (CMC-NHS), induced varying levels of DC activation. In contrast, however, 
RHCIII hydrogels incorporating an additional polymeric network of 2-methacryloyloxyethyl 
phosphorylcholine (MPC) did not activate DC but instead induced DC apoptosis, a phenomenon 
observed in natural matrices. This correlated with increased DC expression of LAIR-1 (leukocyte-
associated immunoglobulin-like receptor-1). Despite low immunogenic potential, viable tolerogenic 
DC migrated into and through both natural and manufactured RHCIII gels. These data show the 
immunogenic potential of RHCIII gels varies with the nature and composition of the gel. Pre-clinical 
evaluation of hydrogel immunogenic/fibrogenic potential is recommended. 
Keywords: dendritic cells, extracellular matrix, collagen hydrogels, activation crosslinkers, 
transplantation, graft 
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1. INTRODUCTION  
 Corneal transplantation is currently the only commonly accepted therapeutic option available 
for corneal blindness, a worldwide unmet medical need (Shankar, Griffith, Forrester, & Kuffová, 2015). 
To address the limited supply of donor human allograft corneas, strategies involving bio-interactive, 
extracellular matrix (ECM)-based artificial corneal substitutes have been proposed (Griffith et al., 
2012). Promising approaches include transplanting host corneal tissue with cell-free recombinant 
human collagen III (RHCIII)-based hydrogels that mimic natural corneas in composition and optical 
properties, and have demonstrated functionality in lamellar implants (i.e. intrastromal non-penetrating 
implants) in both animal models (mini-pigs and rabbits) (Griffith et al., 2012; W. Liu et al., 2008; 
McLaughlin et al., 2010) and in patients (Per Fagerholm et al., 2010; P. Fagerholm et al., 2014). All 
collagen hydrogels in these studies were singly crosslinked using N-(3-dimethylaminopropyl)-N`-
ethylcarbodiimide (EDC) with N-hydroxysuccinimide (NHS) as co-initiator. Mechanical properties 
including tensile strength, elongation at break, elastic modulus, and toughness of those exact RHCIII 
gels used in the present study, were investigated earlier focusing on in vivo myeloid responses (Ahn et 
al., 2013). In addition, a four-year clinical study demonstrated improved visual acuity in patients with 
no signs of rejection and absence of dendritic cells (DC) in lamellar implants composed of singly 
crosslinked RHCIII hydrogels (P. Fagerholm et al., 2014).  
 In terms of reactivity, however, there is a fundamental difference in the host 
inflammatory/immune response to intrastromal lamellar hydrogel implants and hydrogels which 
substitute for all five layers of the cornea (i.e. full thickness hydrogel implants). In particular, lamellar 
implants allow preservation of the host endothelium (the dominant reservoir of immunogenicity in 
grafted corneas). In contrast, full thickness implants, where the integrity of host endothelium is 
compromised, depend upon minimising the wound healing response and development of opaque scar 
tissue (retro-corneal membrane (RCM) formation) to retain transparency. Accordingly, lamellar 
implants have enjoyed some degree of success (P. Fagerholm et al., 2014; Islam et al., 2018; 
Jangamreddy et al., 2018) while full thickness implants do not remain clear due to RCM formation in 
many cases (Hicks & Hamilton, 2005; Obata & Tsuru, 2007; Rajendran, Netuková, Griffith, Forrester, 
 5 
 
& Kuffová, 2017; Yum, Kim, & Kim, 2013). However, they can function as tectonic grafts allowing 
preservation of the eye in the case of a non-healing wound and later replacement with a full thickness, 
endothelium-intact, penetrating allograft. Doubly crosslinked hydrogels, using EDC-NHS crosslinked 
RHCIII gels combined with the synthetic phospholipid polymer, 2-methacryloyloxyethyl 
phosphorylcholine (MPC) crosslinked with poly ethylene glycol diacrylate (PEGDA) were stably 
accepted as tectonic grafts (Buznyk et al., 2015) as well as showing value as anterior lamellar grafts 
(Islam et al., 2018). In a different report (McLaughlin et al., 2010), however, doubly crosslinked 
hydrogels comprising porcine type I collagen with MPC, when grafted into the corneas of guinea pigs 
as full thickness grafts, remained optically clear with no RCM formation. It remains to be clarified, 
however, whether the additional MPC had a role.  
 Although RHCIII hydrogels are usually regarded as non-reactive, and able to successfully 
promote regeneration, like native collagen, they are large biopolymers and relatively difficult to purify 
or customise. Therefore, short peptide mimics of collagen, known as collagen mimetic peptides (CMP) 
or collagen-like peptides (CLP) have been developed (O'Leary, Fallas, Bakota, Kang, & Hartgerink, 
2011; Rubert Pérez et al., 2015). In that respect, a 36 amino-acid long CMP chain (O'Leary et al., 2011) 
was modified by addition of a two amino acid linker (Islam et al., 2016), covalently conjugated to a 
backbone of mechanically tougher polyethylene glycol (PEG), and subsequently crosslinked (Rubert 
Pérez et al., 2015). The resulting CMP-PEG stabilised hydrogels were as effective as full-length 
collagen gels in promoting corneal functional repair as recently shown in mini-pigs (Jangamreddy et 
al., 2018). 
Overcoming immunological challenges is critical for the success of strategies for restoring 
corneal function in corneal allograft (Anderson, Rodriguez, & Chang, 2008; Babensee, 2008; Badylak 
& Gilbert, 2008; Sefton, Babensee, & Woodhouse, 2008; Tang & Eaton, 1995) and similar challenges 
may influence success of full thickness implants. Professional antigen presenting cells such as DC are 
key players in determining the outcome of allograft acceptance (Banchereau & Steinman, 1998; 
Steinman, 2012). Immunogenic materials activate DC, thereby converting “immature” (naïve) DC 
(iDC) into “mature” DC (mDC) with elevated expression of maturation markers such as major 
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histocompatibility complex II (MHCII) and co-stimulatory molecules (CD80, CD86) (Babensee, 2008; 
Badylak & Gilbert, 2008; Sefton et al., 2008). In contrast, tolerogenic materials neither activate DC nor 
initiate an adverse immune response (Janeway & Medzhitov, 2002; van Kooten et al., 2011). The 
chemical and physical properties of biomaterials, including hydrophobicity (Shankar, Petrie, García, & 
Babensee, 2010), control processes such as protein adsorption and complement activation which, as 
extracellular “danger signals” (PAMPs, DAMPs) bind and activate PRR ligands presented on the DC 
surface (Reddy, Swartz, & Hubbell, 2006), determine their immunogenicity. Surgically-induced trauma 
itself may also drive adverse DC-biomaterial interactions (Jones, 2008) resulting in varying extents of 
DC maturation with immunogenic potential (Park & Babensee, 2012). These phenomena have direct 
implications for the use of artificial corneal hydrogels, particularly full thickness hydrogel implants. 
DC present corneal antigens to T cells in the eye-draining lymph node (Dang, Kuffová, Liu, & 
Forrester, 2014; Kuffová et al., 2008) and initiate an allo-specific T cell immune response. T cells are 
also implicated in fibrogenic responses (Farini et al., 2007) which, in the case of rejected corneal grafts 
and failed prostheses, result in formation of dense fibrous membranes on the posterior corneal surface 
(retro-corneal membrane, RCM). It is important to determine whether artificial corneal hydrogels may 
similarly activate DC and promote fibrosis with RCM formation and an increased risk of inflammation.  
The objective of this study was, therefore, to assess the potential risk of differentially 
crosslinked, RHCIII and CMP-PEG hydrogels (Ahn et al., 2013; Rajendran et al., 2017), and their 
individual components to activate DC using in vitro co-culture assays. We also compared the effects of 
natural versus engineered collagen-containing matrices on DC and discuss the implications for 
fabrication of collagen-based hydrogels as corneal implants.  
 
2. MATERIALS AND METHODS  
2.1. Culture of bone marrow dendritic cells (BMDC) on hydrogels 
 Primary BMDC were cultured as described previously (Inaba et al., 1992) and adapted in 
(Martin-Granados et al., 2015). Briefly, hindlimb bones of naïve 5-8 weeks old C57BL/6 mice (bred 
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and maintained in the Medical Research Facility, University of Aberdeen, Scotland, UK) were flushed 
to obtain bone marrow and cells depleted of differentiated cells: T cells [CD4 (GK 1.5), CD8a (53-
6.7)], B cells [CD45R/B220 (IHC)] (all antibodies from BD Biosciences, Franklin Lakes, NJ) and 
MHCII+ cells (P7/7; Serotec), by magnetic bead isolation (Dynal Biotech; Dynabeads sheep anti-rat 
IgG). After seeding (day 0) cells were cultured for another 6 days in the presence of 10 ng/mL 
granulocyte-macrophage colony-stimulating factor (GM-CSF; R&D Systems) in 10 cm Petri dishes 
(Falcon) in DC medium [RPMI 1640 (Gibco Glutamax) with 5 % low IgG foetal calf serum (FCS; 
Gibco) supplemented with 0.2 mM sodium pyruvate (Gibco), 0.1 mM non-essential amino acids 
(NEAA; Gibco) and 10-5 M 2-mercaptoethanol (2-ME; Gibco), 20 U/mL of penicillin, 20 µg/mL of 
streptomycin (both Gibco)]. Medium was replenished on days 2 and 4 of culture. On day 6 of culture 
loosely adherent and adherent fractions were collected following Accutase treatment (Sigma) (2 
mL/dish, 15 min, 37 °C). Cells were pooled, depleted of Gr-1+ granulocytes (RB6-8C5) and the 
resulting population of CD11c+ DC (~70 %) were used to test DC activation. All animal experiments 
complied with the ARRIVE guidelines and were carried out in accordance with the UK Animals 
(Scientific Procedures) Act, 1986 and associated guidelines.  
2.2. Preparation of natural extracellular matrix  
Naturally occurring extracellular matrix (ECM) scaffolds used in this study included 
MatrigelTM (Life Technologies, Paisley, UK) and corneal stromal matrix. MatrigelTM is an endotoxin-
tested, gelatinous, basement membrane mimetic comprising primarily collagen IV, laminin, entactin 
and heparin sulphate proteoglycans from murine tumour stroma (CorningInc., 2018). It was 
reconstituted in situ as soft-gels in flat-bottom 96-well plates (using 80 µL of liquid gel preparation to 
give a 150-200 µm thick soft gel) by incubation at 37 °C, 30 min in 5 % CO2 according to manufacturer 
instructions, prior to DC culture. Corneal stromal matrix was prepared from normal murine corneas 
excised from naïve C57BL/6 mice and de-cellularised as published earlier (Zhang et al., 2015). Briefly, 
corneas were de-cellularised by allowing them to swell in ultrapure water (Baxter; overnight, 4 °C), 
washing alternately with 2 M NaCl or sterile water with shaking three times each (30 min, 4 °C) and 
placed in sterile-filtered 0.2 % Triton X-100 (Sigma; 6 hours, 4 °C). Prior to DC culture, 75 µm thick 
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corneal stromal matrices were sterilised with 3 % (v/v) penicillin-streptomycin (Thermo Scientific) and 
fungizone (Thermo Scientific) overnight at 4 ºC and washed three times with sterile PBS. They were 
then incubated for 48 hours in cell culture media containing said sterilising agents at 37 °C, 5 % CO2 
until use (W. Liu et al., 2008), and positioned in flat-bottom 96-well plates. For ‘natural’ de-
cellularisation of corneas prior to DC culture, egress of resident CD11c+ DCs was promoted by placing 
freshly excised corneal buttons (with their epithelium mechanically abraded) in 6-well plates in media 
(2 ml RPMI with low Ig FCS, 10 mM HEPES, NEAA, penicillin-streptomycin, 2-ME) at 37 °C, 5 % 
CO2 for 6 days with media replenished on days 2 and 4 of culture as described previously (Hamrah, 
Liu, Zhang, & Dana, 2003). 
2.3. Preparation of collagen and collagen mimetic matrices  
Sheets of RHCIII (10 % and 18 % w/w (FibroGen Inc., San Francisco, CA) were crosslinked 
with two different water soluble carbodiimides: N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide or 
N-cyclohexyl-N-(2-morpholinoethyl) carbodiimide metho-p-toulenesulfonate with NHS (CMC-NHS) 
(Sigma-Aldrich, St. Louis, MO), and with co-initiator N-hydroxy succinimide (EDC-NHS) (Sigma-
Aldrich, St. Louis, MO) to generate two singly crosslinked gels, namely EDC-NHS and CMC-NHS 
gels (Table 1).  Details for preparation of these hydrogels are given in (Ahn et al., 2013). Briefly, RHCIII 
was buffered in a syringe mixing system, and pH adjusted to 5 as needed. Then a calculated amount of 
crosslinker was added and mixed in. The molar ratio of EDC to crosslinker:collagen-NH2 (collagen-
NH2 denotes the e- amine groups on collagen molecules) used was 0.4 while that for CMC to achieve 
similar physical hydrogel properties was 1.0. The crosslinking reaction was allowed to proceed at either 
0 ℃ (ice/water bath) for EDC/NHS or 25 ℃ (water bath) for CMC/NHS.  
In addition, to enhance their mechanical properties, some EDC-NHS crosslinked gels 
incorporated a second collagenase-resistant network of 2-methacryloyloxyethyl phosphorylcholine 
(MPC) (Paramount Fine Chemicals Co. Ltd Dalian, China) (hereafter named MPC gels; doubly 
crosslinked) crosslinked with PEGDA as described elsewhere (Hayes et al., 2015). Singly crosslinked 
CMP-PEG hydrogels (100 μm thick) were prepared by conjugation of a 12 % (w/w) solution of CMP 
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(UAB Vildoma, Vilnius, Lithuania) containing a 38 amino acid chain (Cys-Gly-(Pro-Lys-Gly-)4(Pro-
Hyp-Gly)4(Asp-Hyp-Gly)4) to a 400 kD 8-arm polyethylene glycol-maleimide (PEG, Creative 
PEGWorks, Durham, NC, USA) using methods described elsewhere (Islam et al., 2016). The resulting 
CMP-PEG formed a hydrogel after single crosslinking with EDC-NHS (hereafter named CMP-PEG 
crosslinked hydrogel). The molar equivalent of CMP-PEG-NH2:EDC was 1:2, and that of EDC: NHS 
was 1:1. All reagents were thoroughly mixed prior to moulding the hydrogel into flat sheets and leaving 
them in a humidified chamber overnight for crosslinking. All hydrogels were stored in 1 % chloroform 
saturated phosphate buffered saline (PBS; Oxoid Ltd) at 4 °C to maintain sterility. The thickness of all 
of the above mentioned biomaterials amounted to 70 – 150 µm. 
Finally, individual constituents of RHCIII hydrogels as well as endotoxin-tested, purified 
bovine collagen I (Trevigen, Gaithersburg, MD) and bovine collagen III (Southern Biotech, 
Birmingham, AL) were buffered in media and allowed to form soft gels in flat-bottom 96-well plates 
(37 °C, 30 mins, 5 % CO2). Individual components of CMP-PEG hydrogels including unconjugated 
PEG 3,350 monodisperse (50 % w/v; Hampton Research, Aliso Viejo, CA) in ultrapure water (sterile, 
endotoxin-tested) or non-crosslinked peptides alone on PEG backbones (CMP-PEG uncrosslinked) re-
suspended in ultrapure water (< 2 % w/v) and sterile-filtered were also tested. Table 1 and 
Supplementary Figure S4 provide an overview of those natural and fabricated matrices used in this 
study.  
Table 1 here.  
2.4. Dendritic cell activation assay 
Both the naturally derived ECM scaffolds and the fabricated RHCIII (singly- and doubly 
crosslinked) and (singly crosslinked) CMP-PEG hydrogels were tested for their ability to activate bone 
marrow DC by culturing freshly prepared “immature” (naïve) DC (iDC) in the presence of the gels and 
comparing their phenotype with DC cultured in the presence of LPS, a known inducer of “mature” DC 
(mDC). Natural collagen matrices, synthetic collagen hydrogels, and individual hydrogel constituents 
were tested using 96-well flat-bottom tissue culture plates (Thermo Fisher Scientific Inc., Waltham, 
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MA). Gels and reagents were placed in the wells and cells added, at a concentration of 2x105 cells/well 
(in triplicate), and incubated at 37 °C, 5 % CO2. Prior to use, biomaterials were washed twice with 
sterile PBS to remove chloroform, trephined into 5 mm diameter disks to fit exactly in 96-well plates 
and sterilised (as described in 2.2.). Immature DC cultured in the absence of gels or reagents provided 
a negative control while DC cultured with LPS (1 µg/mL; Sigma) provided the mDC positive control. 
Cells were cultured for 24 hours (P. Klaska & V. Forrester, 2015; Vitova et al., 2013), or as indicated 
in Results, and both non-adherent cells (i.e. cells detached from the matrices and floating in the 
supernatant medium) and loosely adherent cells (i.e. cells obtained by gentle aspiration of fresh medium 
to the wells) (Inaba et al., 1992; Martin-Granados et al., 2015) were harvested and analysed by flow 
cytometry. Both engineered hydrogels and natural matrices were also examined for cell invasion by 
confocal microscopy. The phenotypic profiles of adherent or non-adherent DC were assessed using 
flow cytometry (see 2.5. below). The data in this report, unless otherwise stated (see 3.1. in Results), 
are centred on the loosely adherent cell population, since it contains the highest percentage of DC (Inaba 
et al., 1992; Martin-Granados et al., 2015).  
2.5. Flow cytometry   
Dendritic cells cultured with different naturally derived matrices and fabricated gels were 
assessed for their activation status by flow cytometry of cell surface markers and compared to control 
cultures of DC in the absence of gels. Control DC cultured in the absence of gels and without LPS were 
considered immature iDC and with LPS (1.0 µg/mL, 1h) were considered mature (activated) mDC. 
Non-adherent and loosely adherent DC (Satpathy et al., 2012) were separately harvested and stained 
with fluorescently-labelled anti-mouse CD83 (Michel-19), CD86 (GL1), MHCII (AF6-120.1), CD11b 
(M1/70) or CD11c (HL3), all from BD Biosciences. Next, adherent, non-adherent DC, iDC or mDC 
were stained with fluorescently-labelled anti-mouse CD86 (GL1; Biolegend), MHCII (AF6-120.1; BD 
Biosciences), CD11b (M1/70; BD Biosciences), CD11c (HL3; BD Biosciences) and Zbtb46 (U4-1374; 
BD Biosciences) antibodies. Apoptosis was assessed by surface staining for Annexin V (strictly located 
intracellularly in non-apoptotic cells), and necrosis by using the phosphatidyl serine dead cell marker 
7-aminoactinomycin D (7AAD, unable to access intact cells) in Annexin V binding buffer and 
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confirmed using the FLICA-activated poly-caspases assay (all from BD Biosciences). Assays were 
performed as per the manufacturer’s instructions. As positive controls (Pos apo), cells incubated at 70 
°C for 30 min were used to induce apoptotic cell death and establish apoptosis gating strategies. All 
assays were performed as per manufacturers’ protocols. To assess induction of tolerogenicity in gel-
cultured DC, the expression of collagen-binding leukocyte associated immunoglobulin-like receptor-1 
(LAIR-1/CD305) (Nefla, Holzinger, Berenbaum, & Jacques, 2016; L. Sprague et al., 2011) a 
characteristic marker of tolerogenic DC, was measured on the various DC populations (eBioscience, 
San Diego, CA). Samples were stained for 30 mins at 4 °C in the dark in FACS buffer [PBS with 1 % 
(v/v) FCS, 2 mM ethylene diamine tetraacetic acid (EDTA) (Sigma-Aldrich, St. Louis, MO)], washed, 
and analysed using BD LSRII or BD Fortessa flow cytometers (BD Biosciences). Appropriate isotype 
controls or fluorescence minus one (FMO) controls were included to confirm absence of non-specific 
staining or fluorescence spillover, respectively. To assess the effect of the different culture conditions 
on cell cycle progression (i.e. cell proliferation), DNA-content was measured using DAPI nucleotide 
staining. For intracellular staining of the transcription factor Zbtb46, cells were fixed for 10 min using 
1 % (v/v) methanol-free formalin in PBS (both Sigma). For intra-cellular/intra-nuclear staining, cell 
membrane permeabilisation was established over 20 min using permeabilisation buffer (0.1 % Triton 
X-100 in PBS; both Sigma). Data analysis was completed using FlowJo V10 software (Tree Star, 
Ashland, OR).  
2.6. Confocal microscopy 
 Following 24 hours of DC culture (as described in 2.4.), natural matrices or hydrogels were 
fixed in freshly prepared 4 % (v/v) methanol-free formalin (Thermo Scientific) in PBS (15 min, 4°C) 
in flat-bottom 96-well plates, washed three times in PBS (2 min, room temperature (RT)) and incubated 
in absolute methanol (Sigma; 20 min, RT). These were then permeabilised with 0.2 % (v/v) Triton X-
100 overnight at 4 °C, washed and blocked (30 min, RT) with 10 % (v/v) normal mouse serum diluted 
in PBS-BGEN [3 % (w/v) bovine serum albumin (Fisher Scientific), 0.25 % (w/v) gelatin (Sigma), 5 
mM EDTA and 0.025 % octylphenoxypolyethoxyethanol (IGEPAL CA-630; Sigma), in PBS]. The 
samples were then stained with antibodies against fluorescently-labelled mouse MHCII, CD11b, CD11c 
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or LAIR-1 (all from BD Biosciences) at effective concentrations of ~ 5 µg/mL or concentration-
matched isotype controls, in PBS-BGEN overnight at 4 °C and washed. Hydrogels were then stained 
with rhodamine-phalloidin (F-actin; Sigma) to assess cytoskeletal shape (45 min, RT), washed and 
counterstained (20 min, RT) with 4',6-diamidino-2-phenylindol (DAPI; Thermo Fisher) for nuclear 
staining. After washing, hydrogels were mounted in anti-fade Vectashield (Vector Laboratories Inc., 
Burlingame, CA) mounted onto glass slides (Polysine slides, Thermo Scientific,) with coverslips 
(Thermo Fisher) and imaged using an LSM700 confocal microscope (Carl Zeiss, Oberkochen, 
Germany). Microscope settings were optimized uniquely for different gel compositions to compensate 
for gel intrinsic autofluorescence, and with differential interface contrast as necessary and image 
analysed using Zen Black software (Carl Zeiss, Oberkochen, Germany). 
2.7. Transwell® assay to assess DC invasiveness of collagen gels 
To assess the invasive potential of DC through natural matrices and manufactured hydrogels, a 
modified migration assay was performed using a 5 µm pore Transwell® chamber (Corning HTS 
Transwell® 96-well plate, 5 µm polycarbonate membrane). Gels were placed into the upper well of the 
chambers and DC added at a concentration of 2x105 cells/well. Cell migration into the body of the gel 
was measured by the leading front technique in which the distance migrated by the two leading cells 
into the gel was measured, using confocal imaging with an inbuilt micrometer after a fixed time of 3 
hours at 37 °C. The number of cells in this plane was then quantified. Specifications on the respective 
thickness of those natural and manufactured biomaterials used in the Transwell® assay are to be found 
in 2.2 and 2.3, respectively.  
2.8. Transwell® assay to assess chemoattractant potential of collagen gels  
To determine whether natural ECM or collagen hydrogels released components which might 
induce DC migration in a ‘non-contact’ manner, gels were placed in the lower chambers of each 
Transwell®, separated from DC plated in upper culture inserts (3 hours, 37 °C) with media alone. The 
number of DC migrating into the lower chambers was quantified by flow cytometry as percentages of 
the total cells initially added to the upper compartment. Specifications on the respective thickness of 
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those natural and manufactured biomaterials used in the Transwell® assay are to be found in 2.2, 2.3, 
and Figure 5, respectively. 
2.9. Statistical Analysis 
 Statistical analyses were performed using a one-way analysis of variance with Tukey post-hoc 
test (based on homogeneous variances) or Student’s t-test; p ≤ 0.05 considered significant, with 
appropriate comparisons using Graph Pad Prism V.5 (Graph Pad Software, La Jolla, CA) or using IBM 
SPSS 24 (IBM Corp. Released 2016. IBM SPSS Statistics for Windows; Version 24.0.; Armonk, NY: 
IBM Corp.).  
 
3. RESULTS  
3.1. Preparation and phenotyping of immature DC from mouse bone marrow  
 Conventional bone marrow DC (conventional DC, cDC) are classically identified by the 
integrins CD11c and CD11b, both of which are expressed at varying degrees also by other myeloid cells 
(Shortman & Caux, 1997). More recently, the transcription factor Zbtb46 has been shown to be specific 
for conventional/classical DC, which in the bone marrow are considered progenitor/iDC (Meredith et 
al., 2012). In this study, DC were prepared from bone marrow as described (see 2.1. in Methods) and 
the percentage of Zbtb46 expression on the CD11b+CD11c+ DC was found to be >98 %. Culture on 
different gel matrices such as MatrigelTM or the singly crosslinked RHCIII gel CMC-NHS did not 
significantly alter this expression (Supplementary Figure S1). 
 Culture of DC in vitro leads to some degree of maturation/activation in itself, which is reflected 
in the cells’ behaviour (Inaba et al., 1992). Activation of DC with LPS (mDC) induced a significant 
increase in CD86 expression (Figure 1).  
 Dendritic cells cultured on both collagen gels and natural matrices behaved similarly to DC 
grown on cell culture plastic in that they formed three fractions: non-adherent cells, loosely adherent 
clusters, and firmly adherent spread cells. In this study, we have used the loosely adherent DC for the 
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majority of experiments, unless otherwise noted (see 2.4. and 2.5. in Methods and Supplementary 
Figures S1 and S3) as this population of cells contains a higher proportion of DC (Lu et al., 1995). 
Loosely adherent cells (clusters (Inaba et al., 1992)) appear round with minimal or no dendritic 
processes. This morphology is similarly retained among DC across all states of activation. A proportion 
of DC remained firmly attached to the gel surface after 24 h incubation, and some appeared to invade 
the gel. 
3.2. Natural matrices and hydrogels variably activate immature DC  
We undertook a comprehensive study of DC behaviour in response to culture on various 
matrices. The biomaterials used in this study are described in Table 1. Our initial investigation was to 
assess DC activation using flow cytometry. Different gels activated DC to different extents, as 
compared to untreated iDC and LPS treated mDC. Culturing DC on the natural matrices, MatrigelTM 
and de-cellularised cornea, induced no evidence of DC activation, and instead generated a tolerising 
environment for the cells with significantly reduced MHC Class II and CD86 expression, compared to 
the untreated control iDC (Figure 1). Singly crosslinked RHCIII gels mildly increased MHC Class II 
expression (significantly for CMC-NHS and non-significantly for EDC-NHS). In contrast to MHC 
Class II expression, all crosslinked gels induced upregulation of CD86 in DC (Figure 1B). Unlike 
RHCIII gels, CMP-PEG gels singly crosslinked with EDC-NHS did not clearly activate DC, in that 
MHC Class II expression was significantly reduced, and CD86 only mildly increased (Figure 1A and 
B). This showed that the crosslinking process was not necessarily a key factor in DC activation. 
CD83 expression in DC followed a different pattern. As expected, LPS activation of DC mildly 
lowered CD83 expression although this was not significant (Figure 1C). Dendritic cells cultured on 
natural matrices had markedly reduced levels of CD83. The four fabricated hydrogels, however, yielded 
highly variable results. The CMC-NHS singly crosslinked hydrogel showed significantly reduced CD83 
expression in DC while other gels induced significant upregulation of CD83, although to varying 
degrees (Figure 1C). Strong correlations were found between the percentage of cells expressing the 
above activation/maturation markers in the respective culture conditions (Supplementary Figure S2 A-
 15 
 
C) and the level of their expression as measured by gMFI (Supplementary Figure S2 D-F). Interestingly, 
while there were similarly strong correlations between MHC class II expression on Zbtb46+ DC cultured 
on 18 % RHCIII (CMC-NHS) gels and MatrigelTM, CMC-NHS correlated positively while MatrigelTM 
correlated negatively with CD86 expression (Supplementary Figure S1 B-E). This finding supports the 
hypothesis that MatrigelTM generated a particularly non-activating (tolerising) environment for DC.  
For collagen gels that tended to activate DC, neither the amount of collagen present (10 % vs. 
18 %), nor the presence or absence of the crosslinked MPC network appeared to affect the DC activation 
potential (data not shown). Therefore, further experiments were performed using 18 % RHCIII 
hydrogels. In addition, to exclude the possibility that specific gel components induced DC activation, 
we tested native soluble collagen I and III, as well as those components used for generating crosslinked 
collagen gels, namely PEG and CMP-PEG uncrosslinked. (Table 1). Collagens I and III, and CMP-
PEG uncrosslinked did not induce DC activation, while DC exposure to PEG markedly suppressed 
expression of all three activation markers (data not shown).  
Figure 1 here (in b/w in print). 
As indicated above, a small number of firmly adherent DC appeared to infiltrate the gels and it 
was of interest to see whether this reflected their activation status. As shown in Figure 1D, DC 
infiltrating singly crosslinked RHCIII EDC-NHS hydrogels displayed strong surface MHCII expression 
while within also singly crosslinked CMP-PEG hydrogels (inset), MHCII expression was detected only 
intracellularly or dimly on cell surfaces. These data indicated that the comparably greater likelihood of 
RHCIII gels to activate DC was not related to their crosslinks. The same applied to cells infiltrating 
MatrigelTM or corneal stroma which both failed to significantly induce DC.  
 
3.3. Natural matrices and RHCIII hydrogels induce high levels of (apoptotic) cell death in DC  
 Apoptotic cells, including apoptotic DC, when engulfed by antigen presenting cells, promote 
immune tolerance (Kushwah & Hu, 2010). Thus, we investigated whether the collagen matrices used 
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in this study increased apoptosis in DC. Apoptosis was measured following DC culture on different 
biomaterials and compared to that of iDC cultured in their absence. LPS-activated mDC were used as 
a positive control (see 2.4. in Methods).  
 Lipopolysaccharide treatment neither lowered DC viability, nor changed levels of late apoptosis 
(Figure 2; Supplementary Figure S3A). In contrast, DC exposed to natural matrices (MatrigelTM and 
cornea) were significantly less viable and exhibited increased late apoptosis (cornea) (Figure 2A, B, 
and D). Early apoptosis did not significantly increase in either of the biomaterials/test conditions (Figure 
2C). Among the fabricated hydrogels, higher percentages of DC cultured on low-activating singly 
crosslinked CMP-PEG hydrogels were late apoptotic (Figure 2D), while significantly higher numbers 
of DC were detected in CMC-NHS singly crosslinked hydrogel cultures (Figure 2B) as compared to the 
iDC condition. Using a complementary apoptosis assay (FLICA) the latter results were supported in 
that elevated levels of activated poly caspases (indicative of apoptosis) were measured for DC cultured 
on MatrigelTM and CMC-NHS (Supplementary Figure S3 A) relative to iDC. Additionally, apoptosis 
was significantly correlated to an increased number of cells in the sub-G1 cell cycle phase exclusively 
in the MatrigelTM culture condition (Supplementary Figure S3 B and C). In summary, these results 
support the concept that possible tolerogenic properties of natural matrices and crosslinked RHCIII gels 
are reflected in their ability to induce apoptosis.  
3.4. Individual components of RHCIII hydrogels are pro-apoptotic 
Apoptosis levels were quantified for individual hydrogel components and data presented as fold 
change of percentage CD11b+CD11c+ DC relative to iDC. None of those substrates tested exerted a 
pro-apoptotic effect on DC with the exception of PEG (Figure 3). Interestingly, this compound on its 
own was toxic towards DC, while it had no pronounced effect when incorporated into a stable hydrogel 
matrix (CMP-PEG crosslinked) (Figure 2). PEG effects in DC included a decrease in live cells (Figure 
3A) and corresponding increase in dead cells (Figure 3B) as well as relatively increased late apoptosis 
levels (Figure 3D), while it had no clear effect on early apoptosis (Figure 3C). Across all biomaterials 
tested (natural matrices, crosslinked gels and their components), strong and significant correlations were 
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found between fold change in numbers of live DC presence and fold change DC maturation (CD86: R 
0.5773, p 0.0493; and MHCII: R 0.7659, p 0.0037), further emphasizing the association between 
increased DC apoptosis acting as a trigger for DC tolerisation.  
Figure 2 here (in b/w in print).  
Figure 3 here (in b/w in print). 
 
3.5. LAIR-1 mediated recognition of natural matrices or RHCIII hydrogels  
Soluble collagen and collagen matrices are known to be immuno-inhibitory and some of their 
biological effect is due to the leukocyte-associated Ig receptor LAIR-1 (CD305). LAIR-1 is an immuno-
inhibitory, collagen-binding receptor constitutively expressed by various leukocyte types, including DC 
(Meyaard, 2008). We therefore investigated whether LAIR-1 expression was altered in iDC cultured on 
crosslinked collagen matrices. Dendritic cells exposed to both natural and manufactured collagen 
matrices showed an increase in expression of LAIR-1 to varying degrees (Figure 4A). For some 
matrices including MatrigelTM, corneal stroma, singly- and doubly crosslinked RHCIII hydrogels, as 
well as singly crosslinked CMP-PEG, co-upregulation of LAIR-1 with Annexin V was found, indicating 
a link with apoptosis (Figure 4B). This was confirmed by a significant inverse correlation between 
LAIR-1 expression and the number of live DC (Figure 4C). Interestingly, cells which infiltrated the 
fabricated collagen matrices frequently expressed LAIR-1 (Figure 4D).  
Figure 4 here (in b/w in print). 
3.6. Dendritic cells readily migrate through natural matrices and crosslinked hydrogels 
 In their role as immune sentinels, DC traffic through extracellular matrices in their journey from 
the bone marrow to secondary lymphoid tissues (Steinman, 2012). To determine whether DC could also 
invade and migrate through engineered gels we assessed their migration in a modified Transwell® 
system (see 2.7. in Methods). Dendritic cells (2x105) were incubated with the gels in the upper 
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Transwell® chamber (Figure 5A) for 3 hours. A small proportion of DC settled on each gel surface, 
while the majority of cells settled on the Transwell® membrane beneath the gels by passing over the 
gel surface. Accordingly, the percentage of cells migrating into the lower well was not affected by the 
presence of the gel in the upper well except visually in the case of MatrigelTM (Figure 5B), but this 
result is non-significant. Since MatrigelTM was polymerised in situ (see 2.2. in Methods), forming a 
firm, cell impermeable adhesion to the chamber wall, the percentage of cells in the lower well in this 
case was predictably lower (Figure 5B).  
 The Transwell® system was therefore used to estimate the ability of cells to invade natural and 
manufactured crosslinked gels using the leading-front method (Figure 5C). Cells that settled onto the 
various gel surfaces and adhered firmly, generally invaded the gel to varying degrees, depending on the 
nature of the gel. Leading front measurements indicated that DC migrated essentially through the full 
thickness of de-cellularised corneal stroma, and through more than 75 % of the thickness of singly 
crosslinked CMC-NHS, doubly crosslinked EDC-NHS, and singly crosslinked CMP-PEG hydrogels 
(Figure 5C). However, migration into MatrigelTM and singly crosslinked EDC-NHS alone was reduced 
to fifty percent of gel thickness indicating some degree of restriction of gel invasion (Figure 5C).  
 Gels were also assessed for their potential ability to induce DC migration (chemo-attractant 
properties) by placing them in the lower Transwell® chambers and determining contact-free DC 
migration from the lower into the upper chamber. None of the fabricated gels altered the migratory 
activity of DC over iDC controls. However, the natural matrix MatrigelTM in the lower well had a 
significant inhibitory effect on chemotactic DC migration (Figure 5D). 
Figure 5 here (in b/w in print).  
 
4. DISCUSSION  
 Activation of immune cells, particularly innate immune cells, by biomaterials used as surgical 
implants, is a major consideration when determining their suitability. This is particularly relevant in 
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generating material for use as corneal grafts since not only has the material to induce minimal immune 
cell reaction, but also to remain transparent. Recently, activated DC, which are conventionally regarded 
as inducers of de novo T- and B cell adaptive immune responses against foreign antigens, have been 
flagged as having a role in wound healing through induction of B- and T cells. Most T cell subsets, 
including CD4+ (Th1 and Th2), CD8+ and T regulatory cells, have been implicated but a common 
denominator for fibrogenesis appears to be the production/liberation of activated TGF β (Araya & 
Nishimura, 2010; Brodeur et al., 2015; Farini et al., 2007; Kuttkat et al., 2017; L. Liu et al., 2012), 
which is also known to alternatively activate and thereby tolerise DC (Adnan et al., 2016; Naranjo-
Gómez et al., 2011).  
 In some circumstances, the beneficial effects of DC-T cell interaction in promoting fibrogenesis 
has been demonstrated, as in the induction of interstitial fibrosis and left ventricular wall healing after 
myocardial infarction (Lichtman, 2013). In particular, the beneficial effect of CD28+ T cells activated 
via CD80/86+ DC in healing were highlighted, although the precise role of T effector cells versus 
Foxp3+ T regulatory cells remained to be clarified (Lichtman, 2013). While wound healing in the wall 
of the heart is clearly a desirable outcome, wound healing in the cornea may have deleterious functional 
effects if it causes opacification, and more so when this is accompanied by inflammation. This 
particularly affects wound healing in association with surgical implants and prostheses as applied to the 
cornea where the major complication is the formation of RCM (Hicks & Hamilton, 2005; Obata & 
Tsuru, 2007; Yum et al., 2013). These are, in effect, opaque fibrotic capsules (Küchle & Green, 1996) 
which surround the corneal implant (Bakhtiari et al., 2012; Hicks & Hamilton, 2005) and obstruct the 
transmission of light. The role of macrophages and other inflammatory cells in RCM formation is well 
known, and lymphocytes have been identified in RCM tissues surrounding corneal prostheses (Chalam, 
Chokshi, Agarwal, & Edward, 2007) but whether these cells are bystander infiltrating cells or are a 
result of specific DC-T cell activation remains to be clarified.  
 Dendritic cells act as the sentinels of the immune system and survey the host tissues for 
“danger” signals (DAMPs, PAMPs) which include both foreign and damaged host antigens (J. Liu & 
Cao, 2015), as for instance in myocardial infarction (Lichtman, 2013). In homeostasis, DC maintain 
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naïve T cells in an inactivated state and are considered tolerogenic, but when activated by danger 
signals, DC convert to an immunogenic state by expressing cell surface activation markers such as 
CD80/86 and MHC Class II (Schultz et al., 2015). In the present study, we have compared natural 
collagen matrices and their soluble components with engineered recombinant collagen hydrogels, as 
potential corneal substitutes, for their DC activation potential. We show that natural matrices (i.e. 
corneal stroma, and MatrigelTM) and soluble short-chain collagen peptides (CMP) do not activate DC 
(i.e. they remain tolerogenic). Somewhat in contrast, manufactured RHCIII hydrogels have variable 
effects on DC in that the singly crosslinked EDC-NHS gel induces high, and CMC-NHS mild levels of 
DC activation. Addition of a second crosslinked MPC network did not further increase DC activation, 
and in fact in part attenuated it. This is in keeping with reports that MPC has inflammation suppressing 
properties (Kakinoki et al., 2014; Yumoto et al., 2015). In addition, singly crosslinked CMP-PEG had 
minimal effect on DC activation (Figure 1). These data were further supported by strong and mostly 
significant correlations observed between intracellular Zbtb46 expression in DC and their activation 
(Supplementary Figure S1) when cultured on MatrigelTM and singly crosslinked CMC-NHS, 
respectively. Interestingly, a negative correlation was found between CD86 and Zbtb46 following 
culture of DC on MatrigelTM (Supplementary Figure S1 E) emphasizing a possible tolerising effect of 
MatrigelTM on DC (Figure 1B). However, MatrigelTM contains many components in addition to collagen 
Type IV, such as other matrix proteins (CorningInc., 2018) as well as the TGF β cytokine superfamily, 
some members of which are known to be tolerogenic for DC (reviewed in ref. (Seeger, Musso, & 
Sozzani, 2015)). Further partial evidence for a tolerogenic role for collagen matrices was shown in the 
expression of CD83 by DC on exposure to the recombinant hydrogels. CD83 like CD80/86 binds CD28 
on T cells but its expression level correlates with tolerogenicity (Kryczanowsky, Raker, Graulich, 
Domogalla, & Steinbrink, 2016) and in its soluble form, as when shed from the DC surface, acts as a 
negative regulator of T cell activation (Horvatinovich et al., 2017). Dendritic cells, on exposure to both 
singly and doubly crosslinked EDC-NHS/-MPC, upregulated their expression of CD83 while on 
exposure to singly crosslinked CMC-NHS there was a reduced level of CD83 (Figure 1C). However, 
despite the lower MHC Class II and CD86 expression by DC on exposure to the natural matrices 
MatrigelTM and corneal stroma, these matrices did not have an inverse CD83-inducing effect (Figure 
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1A-C). This may reflect the more complex nature of these matrices since they are both extraction 
products, with not all bioactive components identified. 
 In general, therefore, natural collagen and other structural matrix proteins do not induce 
immune responses and are probably tolerogenic (Bayrak, Prüger, Stock, & Seifert, 2013). Similarly, the 
fabricated matrices studied here are probably tolerogenic, but variably so, depending on the respective 
gel chemistry. Soluble collagen bound to tissue culture plastic is known to be non-activating for DC 
(Bayrak et al., 2013) and this is mediated via the collagen receptor LAIR-1 (Leslee Sprague et al., 2014). 
In the present study, both the natural matrices and the engineered collagen gels induced upregulation of 
LAIR-1, although to different degrees (Figure 4A). Exposure of DC to collagen matrices also induced 
variable degrees of apoptosis and cell death (Figure 3), a process which is also strongly linked to 
tolerogenicity (Frodermann et al., 2015; J. Liu & Cao, 2015; Morelli & Larregina, 2016). Importantly, 
there was a remarkable inverse correlation between LAIR-1 expression and numbers of live cell with 
respect to specific natural and manufactured matrices. Clearly, interaction between DC and collagen 
induces apoptosis via signalling mechanisms which involve LAIR-1. Other receptors on DC are known 
to bind collagen such as osteoclast-associated receptor (OSCAR) and glycoprotein VI (GPVI) but these 
are activating receptors and unlikely to be involved in induction of tolerance and promotion of wound 
healing (Zhou et al., 2016). 
 
5. CONCLUSIONS 
As indicated in this report hydrogel-specific DC maturation leading to T cell activation 
promotes fibrosis probably via induction of TGF β1. With regard to the use of fabricated collagen 
implants as artificial corneas it is desirable to limit the degree of fibrosis and particularly inflammation. 
In the case of lamellar intrastromal collagen implants the least DC-activating biomimetic collagen 
matrix would be the implant of choice. However, lamellar implants have application for use only in 
cases of corneal opacification where the endothelium is intact and functional. For many cases of corneal 
blindness, particularly in rural communities of developing nations, full thickness (penetrating) collagen 
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implants would be necessary, and in such cases a level of wound healing sufficient to ensure good 
wound closure is crucial. Therefore, biomaterials with no to minimal DC-activating potential would be 
optimal to allow for corneal regeneration in the absence of inflammation.  
 
6. ACKNOWLEDGEMENTS 
 We are grateful to the Iain Fraser Flow Cytometry Centre, the Microscopy and Histology 
Facility, and the Medical Research Facility at the University of Aberdeen. This work was supported by 
the Royal College of Surgeons of Edinburgh, UK; and Saving Sight in Grampian/Development Trust 
of the University of Aberdeen, UK.  
 
7. CONFLICT OF INTEREST STATEMENT 
The authors CM, SPS, MMI, JVF and LK have no competing interest to declare. MG is a co-founder 
and minority shareholder in UAB Ferentis which holds a UK patent for the 38 aa CMP molecule and 
CMP-PEG hydrogel described in this study (inventor: Jaywant Phopase) and patents pending. 
  
 23 
 
8. REFERENCES 
Adnan, E., Matsumoto, T., Ishizaki, J., Onishi, S., Suemori, K., Yasukawa, M., & Hasegawa, H. (2016). 
Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for 
functional regulatory T cell induction — A comparative study. Clinical Immunology, 
173(Supplement C), 96-108. doi:https://doi.org/10.1016/j.clim.2016.09.007 
Ahn, J. I., Kuffova, L., Merrett, K., Mitra, D., Forrester, J. V., Li, F., & Griffith, M. (2013). Crosslinked 
collagen hydrogels as corneal implants: effects of sterically bulky vs. non-bulky carbodiimides 
as crosslinkers. Acta Biomaterialia, 9(8), 7796-7805. doi:doi: 10.1016/j.actbio.2013.04.014. 
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008). Foreign body reaction to biomaterials. Seminars 
in Immunology, 20(2), 86-100. doi:10.1016/j.smim.2007.11.004 
Araya, J., & Nishimura, S. L. (2010). Fibrogenic Reactions in Lung Disease. Annual Review of Pathology, 
5(1), 77-98. doi:10.1146/annurev.pathol.4.110807.092217 
Babensee, J. E. (2008). Interaction of dendritic cells with biomaterials. Seminars in Immunology, 20(2), 
101-108. doi:10.1016/j.smim.2007.10.013 
Badylak, S. F., & Gilbert, T. W. (2008). Immune response to biologic scaffold materials. Seminars in 
Immunology, 20(2), 109-116. doi:10.1016/j.smim.2007.11.003 
Bakhtiari, P., Chan, C., Welder, J. D., de la Cruz, J., Holland, E. J., & Djalilian, A. R. (2012). Surgical and 
Visual Outcomes of the Type I Boston Keratoprosthesis for the Management of Aniridic 
Fibrosis Syndrome in Congenital Aniridia. American Journal of Ophthalmology, 153(5), 967-
971.e962. doi:http://dx.doi.org/10.1016/j.ajo.2011.10.027 
Banchereau, J., & Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature, 
392(6673), 245-252. doi:10.1038/32588 
Bayrak, A., Prüger, P., Stock, U. A., & Seifert, M. (2013). Absence of Immune Responses with 
Xenogeneic Collagen and Elastin. Tissue Engineering. Part A., 19(13-14), 1592-1600. 
doi:10.1089/ten.tea.2012.0394 
Brodeur, T. Y., Robidoux, T. E., Weinstein, J. S., Craft, J., Swain, S. L., & Marshak-Rothstein, A. (2015). 
IL-21 Promotes Pulmonary Fibrosis through the Induction of Profibrotic CD8+ T Cells. Journal 
of Immunology, 195(11), 5251-5260. doi:10.4049/jimmunol.1500777 
Buznyk, O., Pasyechnikova, N., Islam, M. M., Iakymenko, S., Fagerholm, P., & Griffith, M. (2015). 
Bioengineered Corneas Grafted as Alternatives to Human Donor Corneas in Three High-Risk 
Patients. Clinical and Translational Science, 8(5), 558-562. doi:10.1111/cts.12293 
Chalam, K. V., Chokshi, A., Agarwal, S., & Edward, D. P. (2007). Complications of AlphaCor 
Keratoprosthesis: A Clinicopathologic Report. Cornea, 26(10), 1258-1260. 
doi:10.1097/ICO.0b013e31813e0bd8 
CorningInc. (2018). Corning Matrigel Matrix, Frequently Asked Questions. In (Vol. 2018): 
https://www.corning.com/media/worldwide/cls/documents/CLS-DL-CC-026%20DL.pdf. 
Dang, Z., Kuffová, L., Liu, L., & Forrester, J. (2014). Soluble antigen traffics rapidly and selectively from 
the corneal surface to the eye draining lymph node and activates T cells when codelivered 
with CpG oligonucleotides. Journal of Leukocyte Biology, 95(3), 431-440. 
doi:10.1189/jlb.0612294.  
Fagerholm, P., Lagali, N. S., Merrett, K., Jackson, W. B., Munger, R., Liu, Y., . . . Griffith, M. (2010). A 
Biosynthetic Alternative to Human Donor Tissue for Inducing Corneal Regeneration: 24-Month 
Follow-Up of a Phase 1 Clinical Study. Science Translational Medicine, 2(46), 46ra61.  
Fagerholm, P., Lagali, N. S., Ong, J. A., Merrett, K., Jackson, W. B., Polarek, J. W., . . . Griffith, M. (2014). 
Stable corneal regeneration four years after implantation of a cell-free recombinant human 
collagen scaffold. Biomaterials, 35(8), 2420-2427 doi:doi: 
10.1016/j.biomaterials.2013.11.079. 
Farini, A., Meregalli, M., Belicchi, M., Battistelli, M., Parolini, D., D'Antona, G., . . . Torrente, Y. (2007). 
T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal 
muscles in the scid/mdx mouse. The Journal of Pathology, 213(2), 229-238. 
doi:10.1002/path.2213 
 24 
 
Frodermann, V., van Puijvelde, G. H. M., Wierts, L., Lagraauw, H. M., Foks, A. C., van Santbrink, P. J., . 
. . de Jager, S. C. A. (2015). Oxidized Low-Density Lipoprotein–Induced Apoptotic Dendritic 
Cells as a Novel Therapy for Atherosclerosis. Seminars in Immunology, 194(5), 2208-2218. 
doi:10.4049/jimmunol.1401843 
Griffith, M., Polisetti, N., Kuffova, L., Gallar, J., Forrester, J. V., Vemuganti, G. K., & Fuchsluger, T. A. 
(2012). Regenerative approaches as alternatives to donor allografting for restoration of 
corneal function. The Ocular Surface, 10(3), 170-183. doi:doi: 10.1016/j.jtos.2012.04.004.  
Hamrah, P., Liu, Y., Zhang, Q., & Dana, M. R. (2003). The corneal stroma is endowed with a significant 
number of resident dendritic cells. Investigative Ophthalmology and Visual Science, 44(2), 
581-589. doi:10.1167/iovs.02-0838 
Hayes, S., Lewis, P., Islam, M. M., Doutch, J., Sorensen, T., White, T., . . . Meek, K. M. (2015). The 
structural and optical properties of type III human collagen biosynthetic corneal substitutes. 
Acta Biomaterialia, 25, 121-130. doi:http://dx.doi.org/10.1016/j.actbio.2015.07.009 
Hicks, C. R., & Hamilton, S. (2005). Retroprosthetic Membranes in AlphaCor Patients: Risk Factors and 
Prevention. Cornea, 24(6), 692-698.  
Horvatinovich, J. M., Grogan, E. W., Norris, M., Steinkasserer, A., Lemos, H., Mellor, A. L., . . . 
DeBenedette, M. A. (2017). Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-
2 Complex on CD14+ Monocytes. Journal of Immunology, 198(6), 2286-2301. 
doi:10.4049/jimmunol.1600802 
Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., . . . Steinman, R. M. (1992). 
Generation of large numbers of dendritic cells from mouse bone marrow cultures 
supplemented with granulocyte/macrophage colony-stimulating factor. Journal of 
Experimental Medicine, 176(6), 1693-1702. doi:10.1084/jem.176.6.1693  
Islam, M. M., Buznyk, O., Reddy, J. C., Pasyechnikova, N., Alarcon, E. I., Hayes, S., . . . Griffith, M. (2018). 
Biomaterials-enabled cornea regeneration in patients at high risk for rejection of donor tissue 
transplantation. npj Regenerative Medicine, 3(1), 2. doi:10.1038/s41536-017-0038-8 
Islam, M. M., Ravichandran, R., Olsen, D., Ljunggren, M. K., Fagerholm, P., Lee, C. J., . . . Phopase, J. 
(2016). Self-assembled collagen-like-peptide implants as alternatives to human donor corneal 
transplantation. RSC Advances, 6(61), 55745-55749. doi:10.1039/C6RA08895C 
Janeway, C. A. J., & Medzhitov, R. (2002). Innate immune recognition. Annual Review of Immunology, 
20, 197-216. doi:10.1146/annurev.immunol.20.083001.084359 
Jangamreddy, J. R., Haagdorens, M. K. C., Mirazul Islam, M., Lewis, P., Samanta, A., Fagerholm, P., . . . 
Griffith, M. (2018). Short peptide analogs as alternatives to collagen in pro-regenerative 
corneal implants. Acta Biomaterialia, 69, 120-130. doi:10.1016/j.actbio.2018.01.011 
Jones, K. S. (2008). Effects of biomaterial-induced inflammation on fibrosis and rejection. Seminars in 
Immunology, 20(2), 130-136. doi:10.1016/j.smim.2007.11.005.  
Kakinoki, S., Sakai, Y., Takemura, T., Hanagata, N., Fujisato, T., Ishihara, K., & Yamaoka, T. (2014). Gene 
chip/PCR-array analysis of tissue response to 2-methacryloyloxyethyl phosphorylcholine 
(MPC) polymer surfaces in a mouse subcutaneous transplantation system. Journal of 
Biomaterials Science, Polymer Edition, 25(14-15), 1658-1672. 
doi:10.1080/09205063.2014.939917 
Kryczanowsky, F., Raker, V., Graulich, E., Domogalla, M. P., & Steinbrink, K. (2016). IL-10–Modulated 
Human Dendritic Cells for Clinical Use: Identification of a Stable and Migratory Subset with 
Improved Tolerogenic Activity. Journal of Immunology, 197(9), 3607-3617. 
doi:10.4049/jimmunol.1501769 
Küchle, M., & Green, W. R. (1996). Epithelial ingrowth: a study of 207 histopathologically proven cases. 
German Journal of Ophthalmology, 5(4), 211-223.  
Kuffová, L., Netuková, M., Duncan, L., Porter, A., Stockinger, B., & Forrester, J. V. (2008). Cross 
presentation of antigen on MHC class II via the draining lymph node after corneal 
transplantation in mice. Journal of Immunology, 180(3), 1353-1361. doi:10.4049/
jimmunol.180.3.1353  
 25 
 
Kushwah, R., & Hu, J. (2010). Dendritic Cell Apoptosis: Regulation of Tolerance versus Immunity. 
Journal of Immunology, 185(2), 795-802. doi:10.4049/jimmunol.1000325  
Kuttkat, N., Mohs, A., Ohl, K., Hooiveld, G., Longerich, T., Tenbrock, K., . . . Trautwein, C. (2017). Hepatic 
overexpression of cAMP-responsive element modulator α induces a regulatory T-cell response 
in a murine model of chronic liver disease. Gut. doi:10.1136/gutjnl-2015-311119 
Lichtman, A. H. (2013). The heart of the matter: Protection of the myocardium from T cells. Journal of 
Autoimmunity, 45, 90-96. doi:http://dx.doi.org/10.1016/j.jaut.2013.05.004 
Liu, J., & Cao, X. (2015). Regulatory dendritic cells in autoimmunity: A comprehensive review. Journal 
of Autoimmunity, 63, 1-12. doi:http://dx.doi.org/10.1016/j.jaut.2015.07.011 
Liu, L., Kou, P., Zeng, Q., Pei, G., Li, Y., Liang, H., . . . Chen, S. (2012). CD4+ T Lymphocytes, Especially 
Th2 Cells, Contribute to the Progress of Renal Fibrosis. American Journal of Nephrology, 36(4), 
386-396.  
Liu, W., Merrett, K., Griffith, M., Fagerholm, P., Dravida, S., Heyne, B., . . . Li, F. (2008). Recombinant 
human collagen for tissue engineered corneal substitutes. Biomaterials, 29(9), 1147-1158. 
doi:10.1016/j.biomaterials.2007.11.011 
Lu, L., Hsieh, M., Oriss, T. B., Morel, P. A., Starzl, T. E., Rao, A. S., & Thomson, A. W. (1995). Generation 
of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and 
functional analyses. Immunology, 84(1), 127-134.  
Martin-Granados, C., Prescott, A. R., Le Sommer, S., Klaska, I. P., Yu, T., Muckersie, E., . . . Forrester, J. 
V. (2015). A key role for PTP1B in dendritic cell maturation, migration, and T cell activation. 
Journal of Molecular Cell Biology, 7(6), 517-528. doi:10.1093/jmcb/mjv032. 
McLaughlin, C. R., Acosta, M. C., Luna, C., Liu, W., Belmonte, C., Griffith, M., & Gallar, J. (2010). 
Regeneration of functional nerves within full thickness collagen-phosphorylcholine corneal 
substitute implants in guinea pigs. Biomaterials, 31(10), 2770-2778. doi:doi: 
10.1016/j.biomaterials.2009.12.031. 
Meredith, M. M., Liu, K., Darrasse-Jeze, G., Kamphorst, A. O., Schreiber, H. A., Guermonprez, P., . . . 
Nussenzweig, M. C. (2012). Expression of the zinc finger transcription factor zDC (Zbtb46, 
Btbd4) defines the classical dendritic cell lineage. Journal of Experimental Medicine, 209(6), 
1153-1165. doi:10.1084/jem.20112675 
Meyaard, L. (2008). The inhibitory collagen receptor LAIR-1 (CD305) Journal of Leukocyte Biology, 
83(4), 799-803. doi:doi: 10.1189/jlb.0907609  
Morelli, A. E., & Larregina, A. T. (2016). Concise Review: Mechanisms Behind Apoptotic Cell-Based 
Therapies Against Transplant Rejection and Graft versus Host Disease. Stem Cells, 34(5), 1142-
1150. doi:10.1002/stem.2326 
Naranjo-Gómez, M., Raïch-Regué, D., Oñate, C., Grau-López, L., Ramo-Tello, C., Pujol-Borrell, R., . . . 
Borràs, F. E. (2011). Comparative study of clinical grade human tolerogenic dendritic cells. 
Journal of Translational Medicine, 9(1), 89. doi:10.1186/1479-5876-9-89 
Nefla, M., Holzinger, D., Berenbaum, F., & Jacques, C. (2016). The danger from within: alarmins in 
arthritis. Nature Reviews: Rheumatology, 12(11), 669-683. doi:10.1038/nrrheum.2016.162 
O'Leary, L. E. R., Fallas, J. A., Bakota, E. L., Kang, M. K., & Hartgerink, J. D. (2011). Multi-hierarchical 
self-assembly of a collagen mimetic peptide from triple helix to nanofibre and hydrogel. 
Nature Chemistry, 3(10), 821-828. 
doi:http://www.nature.com/nchem/journal/v3/n10/abs/nchem.1123.html#supplementary-
information 
Obata, H., & Tsuru, T. (2007). Corneal Wound Healing from the Perspective of Keratoplasty Specimens 
With Special Reference to the Function of the Bowman Layer and Descemet Membrane. 
Cornea, 26, S82-S89. doi:10.1097/ICO.0b013e31812f6f1b 
P. Klaska, I., & V. Forrester, J. (2015). Mouse Models of Autoimmune Uveitis. Current Pharmaceutical 
Design, 21(18), 2453-2467.  
Park, J., & Babensee, J. E. (2012). Differential functional effects of biomaterials on dendritic cell 
maturation. Acta Biomaterialia, 8(10), 3606-3617. doi:10.1016/j.actbio.2012.06.006 
 26 
 
Rajendran, V., Netuková, M., Griffith, M., Forrester, J. V., & Kuffová, L. (2017). Mesenchymal stem cell 
therapy for retro-corneal membrane – A clinical challenge in full-thickness transplantation of 
biosynthetic corneal equivalents. Acta Biomaterialia, 64(Supplement C), 346-356. 
doi:https://doi.org/10.1016/j.actbio.2017.10.011 
Reddy, S. T., Swartz, M. A., & Hubbell, J. A. (2006). Targeting dendritic cells with biomaterials: 
developing the next generation of vaccines. Trends in Immunology, 12, 573-579. 
doi:10.1016/j.it.2006.10.005 
Rubert Pérez, C. M., Stephanopoulos, N., Sur, S., Lee, S. S., Newcomb, C., & Stupp, S. I. (2015). The 
Powerful Functions of Peptide-Based Bioactive Matrices for Regenerative Medicine. Annals of 
Biomedical Engineering, 43(3), 501-514. doi:10.1007/s10439-014-1166-6 
Satpathy, A. T., KC, W., Albring, J. C., Edelson, B. T., Kretzer, N. M., Bhattacharya, D., . . . Murphy, K. M. 
(2012). Zbtb46 expression distinguishes classical dendritic cells and their committed 
progenitors from other immune lineages. Journal of Experimental Medicine, 209(6), 1135-
1152. doi:10.1084/jem.20120030 
Schultz, H. S., Nitze, L. M., Zeuthen, L. H., Keller, P., Gruhler, A., Pass, J., . . . Panina, S. (2015). Collagen 
Induces Maturation of Human Monocyte-Derived Dendritic Cells by Signaling through 
Osteoclast-Associated Receptor. Journal of Immunology, 194(7), 3169-3179. 
doi:10.4049/jimmunol.1402800 
Seeger, P., Musso, T., & Sozzani, S. (2015). The TGF-β superfamily in dendritic cell biology. Cytokine 
and Growth Factor Reviews, 26(6), 647-657. 
doi:http://dx.doi.org/10.1016/j.cytogfr.2015.06.002 
Sefton, M. V., Babensee, J. E., & Woodhouse, K. A. (2008). Innate and adaptive immune responses in 
tissue engineering. Seminars in Immunology, 20(2), 83-85 doi:doi: 
10.1016/j.smim.2007.12.008. 
Shankar, S. P., Griffith, M., Forrester, J. V., & Kuffová, L. (2015). Dendritic cells and the extracellular 
matrix: A challenge for maintaining tolerance/homeostasis. World Journal of Immunology, 
5(3), 113-130. doi:10.5411/WJI.v5.i3.113 
Shankar, S. P., Petrie, T. A., García, A. J., & Babensee, J. E. (2010). Dendritic cell responses to self-
assembled monolayers of defined chemistries. Journal of Biomedical Materials Research. Part 
A., 92(4), 1487-1499. doi:10.1002/jbm.a.32487 
Shortman, K., & Caux, C. (1997). Dendritic cell development: multiple pathways to nature's adjuvants. 
Stem Cells, 15, 409-419 doi:DOI: 10.1002/stem.150409 
Sprague, L., Muccioli, M., Pate, M., Meles, E., McGinty, J., Nandigam, H., . . . Benencia, F. (2011). The 
interplay between surfaces and soluble factors define the immunologic and angiogenic 
properties of myeloid dendritic cells. BMC Immunology, 12, 35:31-22. doi:doi: 10.1186/1471-
2172-12-35. 
Sprague, L., Muccioli, M., Pate, M., Singh, M., Xiong, C., Ostermann, A., . . . Benencia, F. (2014). 
Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression 
of collagen receptors in tumors and atherosclerotic microenvironments. Experimental Cell 
Research, 323(1), 7-27. doi:http://dx.doi.org/10.1016/j.yexcr.2014.01.031 
Steinman, R. M. (2012). Decisions about dendritic cells: past, present, and future. Annual Review of 
Immunology, 30, 1-22 doi:DOI: 10.1146/annurev-immunol-100311-102839 
Tang, L., & Eaton, J. W. (1995). Inflammatory responses to biomaterials. American Journal of Clinical 
Pathology, 103(4), 466-471. doi:http://dx.doi.org/10.1093/ajcp/103.4.466  
van Kooten, C., Lombardi, G., Gelderman, K. A., Sagoo, P., Buckland, M., Lechler, R., & Cuturi, M. C. 
(2011). Dendritic cells as a tool to induce transplantation tolerance: obstacles and 
opportunities. Transplantation, 91(1), 2-7. doi:0.1097/TP.0b013e31820263b3 
Vitova, A., Kuffová, L., Klaska, I. P., Holan, V., Cornall, R. J., & Forrester, J. V. (2013). The high-risk 
corneal regraft model: a justification for tissue matching in humans. 26(4), 453-461. 
doi:doi:10.1111/tri.12055 
 27 
 
Yum, H. R., Kim, M. S., & Kim, E. C. (2013). Retrocorneal Membrane After Descemet Membrane 
Endothelial Keratoplasty. Cornea, 32(9), 1288-1290. doi:10.1097/ICO.0b013e318296e0f7 
Yumoto, H., Hirota, K., Hirao, K., Miyazaki, T., Yamamoto, N., Miyamoto, K., . . . Miyake, Y. (2015). Anti-
inflammatory and protective effects of 2-methacryloyloxyethyl phosphorylcholine polymer on 
oral epithelial cells. Journal of Biomedical Materials Research. Part A., 103(2), 555-563. 
doi:doi:10.1002/jbm.a.35201 
Zhang, M. C., Liu, X., Jin, Y., Jiang, D. L., Wei, X. S., & Xie, H. T. (2015). Lamellar keratoplasty treatment 
of fungal corneal ulcers with acellular porcine corneal stroma. American Journal of 
Transplantation, 15(4), 1068-1075. doi:10.1111/ajt.13096. Epub 2015 Mar 11. 
Zhou, L., Hinerman, J. M., Blaszczyk, M., Miller, J. L. C., Conrady, D. G., Barrow, A. D., . . . Herr, A. B. 
(2016). Structural basis for collagen recognition by the immune receptor OSCAR. Blood, 
127(5), 529-537. doi:10.1182/blood-2015-08-667055 
 
  
 28 
 
 
TABLES 
Table 1: Classification and composition of natural and engineered (fabricated/manufactured) 
biomaterials used in this study.  
 
FIGURES  
Figure 1: Comparison of activation of DC by natural matrices (“natural”), or engineered hydrogels 
(“engineered”) to untreated (immature DC, iDC) or LPS-activated (mature DC, mDC) controls (“ctrl”) 
at 24 hours, all cultured on tissue culture plastic. DC maturation marker expression is presented as fold 
change in gMFI for MHCII (A), CD86 (B), and CD83 (C) for CD11b+ CD11c+ cells. Mean ± SD; N = 
3-8, unpaired t test; *different from iDC (p ≤ 0.05, one-way ANOVA with Tukey post-hoc test), 
^different from cornea; levels of significance: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ˂ 0.0001. 
Representative images (N = 3) depicting MHCII expression on DC (with DAPI nucleophilic 
counterstaining) which infiltrated natural matrices or engineered hydrogels; 40X magnification (inset 
20X), scale bar 20 µm (D).  
 
Figure 2: Increased levels of apoptosis in CD11b+CD11c+ DC cultured for 24 hours on natural matrices 
(“natural”) or engineered hydrogels (“engineered”) versus untreated and LPS-activated controls 
(“ctrl”), all cultured on tissue culture plastic. Percentages of cells are expressed as fold change over the 
negative control (iDC). Live: unstained (A), dead: 7-AAD positive (B), early apoptotic: Annexin V 
positive (C), and late apoptotic: double positive for 7-AAD and Annexin V (D) CD11b+CD11c+ DC, 
following culture over natural matrices or engineered hydrogels. Mean ± SD; N = 3-8, one-way 
ANOVA with Tukey post-hoc test, ***different from iDC (p ≤ 0.0001).  
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Figure 3: Effect of individual components of biomaterials (“components”) on DC apoptosis compared 
to untreated (iDC) or LPS-activated DC (mDC) controls (“ctrl”). Percentages of cells are expressed as 
fold change over the negative control (iDC). Live: unstained (A), dead: 7-AAD positive (B), early 
apoptotic: Annexin V positive (C), and late apoptotic: double positive for 7-AAD and Annexin V (D) 
CD11b+CD11c+ DC are depicted, following culture with individual biomaterial components. Mean ± 
SD; N = 3-8, one-way ANOVA with Tukey post-hoc test, *different from iDC and mDC (p ≤ 0.05).   
 
Figure 4: Comparison of LAIR-1 expression by CD11b+CD11c+ DC cultured for 24 hours on natural 
matrices (“natural”) or engineered hydrogels (“engineered”) versus untreated and LPS-activated 
controls (“ctrl”), all cultured on tissue culture plastic. Increased expression of LAIR-1 was observed in 
DC cultured on MatrigelTM, singly crosslinked CMC-NHS or doubly crosslinked MPC RHCIII 
hydrogels, but not after culture on singly crosslinked CMP-PEG hydrogels over the negative control 
(iDC). Fold change in LAIR-1 based on gMFI (A), or fold change based on percentages of Annexin V+ 
LAIR-1+ DC (B); mean ± SD; N = 3, unpaired t test, *different from iDC, *p ≤ 0.05, **p ≤ 0.01, ***p 
≤ 0.001, ****p ˂ 0.0001. A strongly negative correlation (C) was found between fold change gMFI 
LAIR-1 expression and fold change percentage live DC (both over iDC) for different biomaterials 
(mean ± SD; N = 3, R: Pearson’s coefficient -1 ≤ 0 ≤ 1; two-tailed p ≤ 0.05 is significant). Representative 
images (n = 3) showing LAIR-1 expression (with DAPI nucleophilic staining) on DC which infiltrated 
into natural materials or engineered hydrogels during 24 h culture (D).  
 
Figure 5: Schematic of migration assay Transwell® chamber system with natural matrix (“natural”) or 
engineered hydrogel (“engineered”) placed on membrane in upper chamber (A). Percental migratory 
cell events detected in lower chambers are presented (mean ± SD; N = 3, unpaired t-test) (B). Depth of 
leading edge across biomaterials are presented as percentages of total material thickness (mean ± SD; 
N = 3, unpaired t test, *different from iDC, *p ≤ 0.05) (C). Chemotactic (“non-contact”) migratory cell 
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events from lower to upper chamber presented as fold change over iDC controls (“ctrl”) (mean ± SD; 
N = 3; unpaired t test *different from iDC, ****p ˂ 0.0001) (D). 
 
Graphical abstract: Bone marrow immature dendritic cells (iDC) were cultured on a series of engineered 
differentially cross-linked hydrogels containing recombinant human collagen (RHCIII) or collagen 
mimetic peptide (CMP). Upon culture of DC over the different hydrogels cell surface expression of 
activation/maturation markers (CD86, MHC II) was assessed and compared to controls (natural 
matrices).  
Left: Natural matrices (MatrigelTM and de-cellularized mouse corneal stroma) induced no DC activation 
and maintained their “tolerogenic” status (tolDC). The same was true for the cross-linked collagen 
mimetic peptide CMP-PEG hydrogel. The RHCIII gel CMC-NHS crosslinked with N-cyclohexyl-N-
(2-morpholinoethyl) carbodiimide metho-p-toulenesulfonate with N-hydroxy succinimide (NHS) was 
only low activating.  
Right: In contrast, the RHCIII gel cross-linked with N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
containing the co-initiator N-hydroxy succinimide (EDC-NHS) or (CMC-NHS gels) induced high 
levels of DC activation, generating mature DC (mDC).  
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Table 1 
 Matrix descriptor Constituents/composition Basic crosslinking 
agent 
Additional 
crosslinking agent 
Degree of 
crosslinking 
Full denomination 
 
 
 
 
“Natural gels” 
“Cornea” 
 
Collagen I, V, VII none none none Corneal stroma 
“MatrigelTM” 
 
Collagen IV, laminin, entactin 
(CorningInc., 2018) 
 
none none none MatrigelTM 
“Collagen I” 
 
Collagen I 
 
 
none none none Collagen type I 
“Collagen III” 
 
Collagen III 
 
 
none none none Collagen type III 
  
 
 
 
 
 
“Engineered 
gels” 
“MPC” 
 
10 % collagen (RHCIII) 
18 % collagen (RHCIII) 
 
EDC-NHS MPC 2 
“doubly-crosslinked” 
RHCIII (10 %) EDC-NHS-MPC 
RHCIII (18 %) EDC-NHS-MPC 
“EDC-NHS” 10 % collagen (RHCIII) 
18 % collagen (RHCIII) 
 
EDC-NHS none 1 
“singly-crosslinked” 
RHCIII (10 %) EDC-NHS 
RHCIII (18 %) EDC-NHS 
“CMC-NHS” 10 % collagen (RHCIII) 
18 % collagen (RHCIII) 
 
CMC-NHS none 1 
“singly-crosslinked” 
RHCIII (10 %) CMC-NHS 
RHCIII (18 %) CMC-NHS 
“CMP-PEG 
crosslinked” 
Collagen mimetic peptide, 
PEG backbone (“CMP-PEG 
uncrosslinked”) 
 
EDC-NHS none 1 
“singly-crosslinked” 
CMP-PEG EDC-NHS 
EDC-NHS: N-(3-dimethylaminopropyl)-N`-ethylcarbodiimide;N-hydroxysuccinimide  
MPC: 2-methacryloyloxyethyl phosphorylcholine  
CMC-NHS: N-cyclohexyl-N’-(2-morpholinoethyl)carbodiimidemetho-p-toluenesulphonate 
CMP: Collagen Mimetic Peptide [(Pro-Lys-Gly)4(Pro-Hyp-Gly)4(Asp-Hyp-Gly)4];  
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Table 1: Classification and composition of natural and engineered (fabricated/manufactured) biomaterials used in this study. 
 
